Contact
Please use this form to send email to PR contact of this press release:
Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED
TO:
Please use this form to send email to PR contact of this press release:
Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED
TO: